Orthox Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 20
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $314K
Latest Deal Amount
  • Investors
  • 8

Orthox General Information


Developer of tissue regenerative implants intended to address large injuries to cartilage tissues in which early OA may be present. The company's tough, resilient, hydrogel implants are developed with the purpose of rapidly restoring knee function while allowing the body's own cells to grow through and integrate with the device, enabling patients to return to a fully active and pain-free lifestyle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Other Devices and Supplies
Primary Office
  • 66 Innovation Drive
  • Milton Park
  • Oxfordshire OX14 4RQ
  • England, United Kingdom
+44 01235 000000

Orthox Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC $314K 00.00 Completed Clinical Trials - Phase 1
13. Later Stage VC 01-Sep-2020 00000 00.00 Completed Clinical Trials - Phase 1
12. Grant 01-Jul-2020 00.000 00.000 Completed Clinical Trials - Phase 1
11. Grant 01-Oct-2018 00.000 00.000 Completed Generating Revenue
10. Later Stage VC 01-Aug-2018 00.000 00.000 Completed Generating Revenue
9. Grant 01-Jul-2015 00.000 00.000 Completed Generating Revenue
8. Later Stage VC 01-Jun-2015 00.000 00.000 Completed Pre-Clinical Trials
7. Grant 29-Oct-2013 00.000 Completed Startup
6. Grant 01-May-2012 $658K Completed Startup
5. Grant 01-May-2011 $1.4M Completed Startup
To view Orthox’s complete valuation and funding history, request access »

Orthox Executive Team (4)

Name Title Board Seat Contact Info
Nicholas Skaer Ph.D Co-Founder, Chief Scientist, Chief Executive Officer, Research Director & Board Member
Robert Walker Chief Technical Officer
Sarah Nurse Operations Director
Oliver Kessler MD Co-Founder, Chief Medical Officer, Medical Director & Board Member
To view Orthox’s complete executive team members history, request access »

Orthox Board Members (10)

Name Representing Role Since
Allan Ritchie Orthox Board Member 000 0000
David Knight Orthox Board Member 000 0000
Friedrich Vollrath Self Board Member 000 0000
Henry Sykes Orthox Board Member 000 0000
James Mallinson Oxford Spin-out Equity Management Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Orthox Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orthox Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Health Accelerator/Incubator 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Hugo Sykes Angel (individual) Minority 000 0000 000000 0
Oxford Investment Consultants Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »